CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- NT 10-Q Other NT 10-Q
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- NT 10-K Other NT 10-K
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- SC 13D Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 10-Q/A Report 10-Q/A
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- NT 10-Q Other NT 10-Q
- 8-K Event Unregistered share sale · Other events
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
Page 30 of 46 · 904 filings